ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - EPA:AKE - FR0010313833 - Common Stock
58.25 EUR
-0.45 (-0.77%)
Taking everything into account, AKE scores 5 out of 10 in our fundamental rating. AKE was compared to 66 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
AKE had positive earnings in the past year.
In the past year AKE had a positive cash flow from operations.
In the past 5 years AKE has always been profitable.
AKE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AKE has a Return On Assets (1.51%) which is in line with its industry peers.
AKE has a Return On Equity (2.90%) which is in line with its industry peers.
With a Return On Invested Capital value of 3.44%, AKE perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 6.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
Looking at the Profit Margin, with a value of 2.22%, AKE is in line with its industry, outperforming 56.06% of the companies in the same industry.
AKE's Profit Margin has declined in the last couple of years.
AKE has a Operating Margin (6.35%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AKE has declined.
AKE has a Gross Margin of 19.02%. This is in the lower half of the industry: AKE underperforms 74.24% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
AKE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
The debt/assets ratio for AKE is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.91 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKE has a worse Altman-Z score (1.91) than 60.61% of its industry peers.
AKE has a debt to FCF ratio of 16.70. This is a negative value and a sign of low solvency as AKE would need 16.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.70, AKE is in line with its industry, outperforming 56.06% of the companies in the same industry.
AKE has a Debt/Equity ratio of 0.50. This is a neutral value indicating AKE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, AKE is in line with its industry, outperforming 45.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.69
WACC5.02%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
AKE has a better Current ratio (2.73) than 78.79% of its industry peers.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a Quick ratio of 1.92. This is amongst the best in the industry. AKE outperforms 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The earnings per share for AKE have decreased strongly by -24.85% in the last year.
The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
The Revenue has been growing slightly by 0.19% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%
3.2 Future
AKE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.75% yearly.
The Revenue is expected to grow by 1.26% on average over the next years.
EPS Next Y-28.82%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
EPS Next 5Y2.75%
Revenue Next Year-3%
Revenue Next 2Y0.08%
Revenue Next 3Y1.44%
Revenue Next 5Y1.26%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AKE is valuated reasonably with a Price/Earnings ratio of 9.13.
Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 95.45% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. AKE is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.21, which indicates a very decent valuation of AKE.
AKE's Price/Forward Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 96.97% of the companies in the same industry.
AKE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 8.21 |
4.2 Price Multiples
93.94% of the companies in the same industry are more expensive than AKE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a somewhat cheap valuation: AKE is cheaper than 77.27% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.52 | ||
| EV/EBITDA | 4.83 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)93.42
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.15%, AKE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.04, AKE pays a better dividend. On top of this AKE pays more dividend than 93.94% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.15% |
5.2 History
The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
AKE pays out 129.52% of its income as dividend. This is not a sustainable payout ratio.
AKE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP129.52%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
EPA:AKE (9/17/2025, 5:35:30 PM)
58.25
-0.45 (-0.77%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners55.8%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.43B
Analysts75.24
Price Target78.47 (34.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.15% |
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-1.37%
PT rev (3m)-16.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)-26.83%
EPS NY rev (3m)-26.83%
Revenue NQ rev (1m)0.69%
Revenue NQ rev (3m)-11.64%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-4.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 8.21 | ||
| P/S | 0.47 | ||
| P/FCF | 19.52 | ||
| P/OCF | 4.36 | ||
| P/B | 0.61 | ||
| P/tB | 2.07 | ||
| EV/EBITDA | 4.83 |
EPS(TTM)6.38
EY10.95%
EPS(NY)7.1
Fwd EY12.19%
FCF(TTM)2.98
FCFY5.12%
OCF(TTM)13.36
OCFY22.93%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)93.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.91 |
F-Score5
WACC5.02%
ROIC/WACC0.69
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
EPS Next Y-28.82%
EPS Next 2Y-7.02%
EPS Next 3Y-0.18%
EPS Next 5Y2.75%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%
Revenue Next Year-3%
Revenue Next 2Y0.08%
Revenue Next 3Y1.44%
Revenue Next 5Y1.26%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year69.34%
EBIT Next 3Y25.14%
EBIT Next 5Y15.99%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%